ITUB20155223A1 - DRY SPRAYING COMPOSITION AND ITS EXTERNAL TOPIC USE IN VETERINARY APPLICATIONS - Google Patents
DRY SPRAYING COMPOSITION AND ITS EXTERNAL TOPIC USE IN VETERINARY APPLICATIONS Download PDFInfo
- Publication number
- ITUB20155223A1 ITUB20155223A1 ITUB2015A005223A ITUB20155223A ITUB20155223A1 IT UB20155223 A1 ITUB20155223 A1 IT UB20155223A1 IT UB2015A005223 A ITUB2015A005223 A IT UB2015A005223A IT UB20155223 A ITUB20155223 A IT UB20155223A IT UB20155223 A1 ITUB20155223 A1 IT UB20155223A1
- Authority
- IT
- Italy
- Prior art keywords
- weight
- essential oil
- sprayable composition
- composition
- dry
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 74
- 238000005507 spraying Methods 0.000 title claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 47
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 34
- 239000003242 anti bacterial agent Substances 0.000 claims description 22
- 239000011787 zinc oxide Substances 0.000 claims description 17
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 16
- 239000013003 healing agent Substances 0.000 claims description 16
- 208000017520 skin disease Diseases 0.000 claims description 16
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 14
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 12
- 239000007921 spray Substances 0.000 claims description 12
- 201000004624 Dermatitis Diseases 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 10
- 206010015150 Erythema Diseases 0.000 claims description 9
- 229910021607 Silver chloride Inorganic materials 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 9
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 claims description 8
- 239000003380 propellant Substances 0.000 claims description 8
- 239000004408 titanium dioxide Substances 0.000 claims description 8
- 239000000576 food coloring agent Substances 0.000 claims description 7
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 6
- 241000208983 Arnica Species 0.000 claims description 6
- 235000003880 Calendula Nutrition 0.000 claims description 6
- 240000001432 Calendula officinalis Species 0.000 claims description 6
- 208000035874 Excoriation Diseases 0.000 claims description 6
- 231100000321 erythema Toxicity 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 239000003974 emollient agent Substances 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- 206010003694 Atrophy Diseases 0.000 claims description 3
- 241000222122 Candida albicans Species 0.000 claims description 3
- 206010007134 Candida infections Diseases 0.000 claims description 3
- 206010007882 Cellulitis Diseases 0.000 claims description 3
- 206010012455 Dermatitis exfoliative Diseases 0.000 claims description 3
- 206010048768 Dermatosis Diseases 0.000 claims description 3
- 206010016936 Folliculitis Diseases 0.000 claims description 3
- 206010017553 Furuncle Diseases 0.000 claims description 3
- 208000034693 Laceration Diseases 0.000 claims description 3
- 206010024438 Lichenification Diseases 0.000 claims description 3
- 206010033733 Papule Diseases 0.000 claims description 3
- 201000004681 Psoriasis Diseases 0.000 claims description 3
- 208000006311 Pyoderma Diseases 0.000 claims description 3
- 206010037888 Rash pustular Diseases 0.000 claims description 3
- 206010039509 Scab Diseases 0.000 claims description 3
- 206010040844 Skin exfoliation Diseases 0.000 claims description 3
- 208000025865 Ulcer Diseases 0.000 claims description 3
- 208000024780 Urticaria Diseases 0.000 claims description 3
- 238000005299 abrasion Methods 0.000 claims description 3
- 206010000269 abscess Diseases 0.000 claims description 3
- 208000010668 atopic eczema Diseases 0.000 claims description 3
- 230000037444 atrophy Effects 0.000 claims description 3
- 201000003984 candidiasis Diseases 0.000 claims description 3
- 208000031513 cyst Diseases 0.000 claims description 3
- 230000003628 erosive effect Effects 0.000 claims description 3
- 208000003512 furunculosis Diseases 0.000 claims description 3
- 206010023332 keratitis Diseases 0.000 claims description 3
- 208000037935 pododermatitis Diseases 0.000 claims description 3
- 208000029561 pustule Diseases 0.000 claims description 3
- 231100000397 ulcer Toxicity 0.000 claims description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 2
- 240000003553 Leptospermum scoparium Species 0.000 claims description 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 2
- 206010043189 Telangiectasia Diseases 0.000 claims description 2
- 244000045947 parasite Species 0.000 claims description 2
- 208000009056 telangiectasis Diseases 0.000 claims description 2
- 241000132025 Calendula Species 0.000 claims 1
- 208000020693 Demodicidosis Diseases 0.000 claims 1
- 206010060708 Induration Diseases 0.000 claims 1
- 230000003071 parasitic effect Effects 0.000 claims 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- 241000605721 Dichelobacter nodosus Species 0.000 description 5
- 241000378544 Melaleuca quinquenervia Species 0.000 description 5
- 244000099147 Ananas comosus Species 0.000 description 4
- 235000007119 Ananas comosus Nutrition 0.000 description 4
- 240000003538 Chamaemelum nobile Species 0.000 description 4
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 4
- 241000605952 Fusobacterium necrophorum Species 0.000 description 4
- 244000165082 Lavanda vera Species 0.000 description 4
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 4
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 4
- 235000015926 Proboscidea louisianica ssp. fragrans Nutrition 0.000 description 4
- 235000015925 Proboscidea louisianica subsp. louisianica Nutrition 0.000 description 4
- 235000019096 Proboscidea parviflora Nutrition 0.000 description 4
- 241001092387 Spiraea Species 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- 239000001102 lavandula vera Substances 0.000 description 4
- 235000018219 lavender Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 240000000982 Malva neglecta Species 0.000 description 3
- 235000000060 Malva neglecta Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 239000001294 propane Substances 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 244000166124 Eucalyptus globulus Species 0.000 description 2
- 240000006236 Martynia annua Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 description 2
- 240000002657 Thymus vulgaris Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940096898 glyceryl palmitate Drugs 0.000 description 2
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 2
- 239000001282 iso-butane Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000003619 porokeratosis Diseases 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- -1 silver carboxylate Chemical class 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000001585 thymus vulgaris Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- FRCHKSNAZZFGCA-UHFFFAOYSA-N 1,1-dichloro-1-fluoroethane Chemical compound CC(F)(Cl)Cl FRCHKSNAZZFGCA-UHFFFAOYSA-N 0.000 description 1
- NPNPZTNLOVBDOC-UHFFFAOYSA-N 1,1-difluoroethane Chemical compound CC(F)F NPNPZTNLOVBDOC-UHFFFAOYSA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N 1-monopalmitoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ODMZDMMTKHXXKA-QXMHVHEDSA-N 8-methylnonyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCCCCCC(C)C ODMZDMMTKHXXKA-QXMHVHEDSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- VOPWNXZWBYDODV-UHFFFAOYSA-N Chlorodifluoromethane Chemical compound FC(F)Cl VOPWNXZWBYDODV-UHFFFAOYSA-N 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 244000308760 Helichrysum petiolatum Species 0.000 description 1
- 240000001812 Hyssopus officinalis Species 0.000 description 1
- 235000010650 Hyssopus officinalis Nutrition 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 235000001167 Melaleuca cajuputi Nutrition 0.000 description 1
- 235000017710 Melaleuca viridiflora Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000031816 Pathologic Dilatation Diseases 0.000 description 1
- 244000082490 Proboscidea louisianica Species 0.000 description 1
- 244000023431 Proboscidea parviflora Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 description 1
- 240000001519 Verbena officinalis Species 0.000 description 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 description 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 description 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 229910052946 acanthite Inorganic materials 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000006030 antibiotic growth promoter Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- SAOKZLXYCUGLFA-UHFFFAOYSA-N bis(2-ethylhexyl) adipate Chemical compound CCCCC(CC)COC(=O)CCCCC(=O)OCC(CC)CCCC SAOKZLXYCUGLFA-UHFFFAOYSA-N 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229940093528 cetearyl ethylhexanoate Drugs 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- SHFGJEQAOUMGJM-UHFFFAOYSA-N dialuminum dipotassium disodium dioxosilane iron(3+) oxocalcium oxomagnesium oxygen(2-) Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[Fe+3].[Fe+3].O=[Mg].O=[Ca].O=[Si]=O SHFGJEQAOUMGJM-UHFFFAOYSA-N 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 229940067572 diethylhexyl adipate Drugs 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000010436 fluorite Substances 0.000 description 1
- 238000004388 gamma ray sterilization Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 210000000003 hoof Anatomy 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- KKKDGYXNGYJJRX-UHFFFAOYSA-M silver nitrite Chemical compound [Ag+].[O-]N=O KKKDGYXNGYJJRX-UHFFFAOYSA-M 0.000 description 1
- XNGYKPINNDWGGF-UHFFFAOYSA-L silver oxalate Chemical compound [Ag+].[Ag+].[O-]C(=O)C([O-])=O XNGYKPINNDWGGF-UHFFFAOYSA-L 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229940019931 silver phosphate Drugs 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 229940056910 silver sulfide Drugs 0.000 description 1
- XUARKZBEFFVFRG-UHFFFAOYSA-N silver sulfide Chemical compound [S-2].[Ag+].[Ag+] XUARKZBEFFVFRG-UHFFFAOYSA-N 0.000 description 1
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 description 1
- RHUVFRWZKMEWNS-UHFFFAOYSA-M silver thiocyanate Chemical compound [Ag+].[S-]C#N RHUVFRWZKMEWNS-UHFFFAOYSA-M 0.000 description 1
- CHACQUSVOVNARW-LNKPDPKZSA-M silver;(z)-4-oxopent-2-en-2-olate Chemical compound [Ag+].C\C([O-])=C\C(C)=O CHACQUSVOVNARW-LNKPDPKZSA-M 0.000 description 1
- LMEWRZSPCQHBOB-UHFFFAOYSA-M silver;2-hydroxypropanoate Chemical compound [Ag+].CC(O)C([O-])=O LMEWRZSPCQHBOB-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
- 229940029284 trichlorofluoromethane Drugs 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
Description
“COMPOSIZIONE SPRUZZARTI E SECCA E SUO USO TOPICO ESTERNO IN APPLICAZIONI VETERINARIE” "SPRUZZARTI E DRY COMPOSITION AND ITS EXTERNAL TOPICAL USE IN VETERINARY APPLICATIONS"
CAMPO DELL'INVENZIONE FIELD OF THE INVENTION
La presente invenzione riguarda una composizione spruzzabile secca avente proprietà cicatrizzanti, disinfettanti ed antinfiammatorie, nonché il suo uso topico esterno in applicazioni veterinarie. The present invention relates to a dry sprayable composition having healing, disinfectant and anti-inflammatory properties, as well as its external topical use in veterinary applications.
STATO DELLA TECNICA STATE OF THE TECHNIQUE
Nel settore zootecnico e veterinario in generale, le affezioni cutanee sia nel caso di animali da reddito che di animali da compagnia sono comuni e possono essere aggravate dall’ insorgenza di prurito cui Γ animale reagisce peggiorando la situazione, ad esempio, grattandosi, mordicchiandosi o strusciandosi. In the zootechnical and veterinary sector in general, skin diseases both in the case of farm animals and pets are common and can be aggravated by the onset of itching to which the animal reacts by worsening the situation, for example, by scratching, nibbling or rubbing. .
Spesso, le affezioni cutanee sono tali da richiedere un trattamento antibiotico della durata di diverse settimane. Often, skin conditions are such that they require antibiotic treatment lasting several weeks.
Tuttavia, Γ abuso e l’utilizzo inappropriato degli antibiotici hanno contribuito alla comparsa di batteri resistenti. Il problema è ulteriormente aggravato dalla autoprescrizione di antibiotici da parte di individui che non consultano un veterinario qualificato, e dall’uso non terapeutico degli antibiotici come promotori della crescita in agricoltura. Gli antibiotici vengono inoltre spesso prescritti per situazioni in cui il loro uso non è giustificato. However, abuse and inappropriate use of antibiotics have contributed to the emergence of resistant bacteria. The problem is further aggravated by the self-prescription of antibiotics by individuals who do not consult a qualified veterinarian, and by the non-therapeutic use of antibiotics as growth promoters in agriculture. Antibiotics are also often prescribed for situations where their use is not justified.
È pertanto sentita l’esigenza di trattare adeguatamente ed efficacemente il problema delle affezioni cutanee, evitando l’uso di antibiotici. The need is therefore felt to adequately and effectively treat the problem of skin diseases, avoiding the use of antibiotics.
È quindi scopo della presente invenzione fornire una soluzione economica ed efficace, che non preveda il ricorso ad antibiotici. It is therefore an object of the present invention to provide an economical and effective solution, which does not require the use of antibiotics.
RIASSUNTO DELL’INVENZIONE SUMMARY OF THE INVENTION
Detto scopo è stato raggiunto mediante una composizione spruzzabile secca, come da rivendicazione 1. Said object has been achieved by means of a dry sprayable composition, as per claim 1.
Con il termine “secca” si intende che la composizione spruzzabile è preferibilmente anidra, ma può contenere un residuo di acqua in quantità non superiore a 2% in peso sul peso della composizione. The term "dry" means that the sprayable composition is preferably anhydrous, but may contain a water residue in an amount not exceeding 2% by weight on the weight of the composition.
Sotto un altro aspetto, la presente invenzione concerne l’uso topico esterno di tale composizione spruzzabile secca nel trattamento di affezioni cutanee animali, in cui detta composizione è applicata per spruzzatura. From another aspect, the present invention relates to the external topical use of this dry sprayable composition in the treatment of animal skin diseases, in which said composition is applied by spraying.
Con il termine “affezioni cutanee” si intende macchie, papule, vesciche, bolle, pustole, cisti, erosioni, abrasioni, arrossamenti, ulcere, screpolature, piaghe, telangectasia, desquamazioni, eritemi, croste, lichenificazioni, escoriazioni, indurimenti, tagli, lacerazioni, o atrofìe. Tali affezioni cutanee sono la manifestazione di malattie della cute quali dermatiti, dermatiti digitali ed interdigitali, pododermatiti, piodermiti, dermatosi, foruncolosi, candidosi, eritrodermia, eritema, ustioni, follicolite, tricomicosi, cheratite, eczema, psoriasi, porocheratosi, orticaria, rogna demodettica, malasseziasi, parassitosi, ascessi, flemmoni, zoppina. The term "skin affections" means spots, papules, blisters, blisters, pustules, cysts, erosions, abrasions, redness, ulcers, cracks, sores, telangiectasia, desquamation, erythema, scabs, lichenification, excoriation, hardening, cuts, lacerations , or atrophies. These skin diseases are the manifestation of skin diseases such as dermatitis, digital and interdigital dermatitis, pododermatitis, pyoderma, dermatosis, furunculosis, candidiasis, erythroderma, erythema, burns, folliculitis, trichomycosis, keratitis, eczema, psoriasis, porokeratosis, urticaria, mange , malasseziasis, parasitosis, abscesses, phlegmons, limp.
Sotto un ulteriore aspetto, la presente invenzione concerne un dispositivo spruzzatore pressurizzato avente un attuatore spray ed un contenitore connesso a detto attuatore, comprendente la composizione spruzzabile secca ed almeno un agente propellente. Le caratteristiche ed i vantaggi della presente invenzione risulteranno evidenti dalla seguente descrizione dettagliata e dalle forme realizzati ve fornite a titolo di esempi illustrativi e non limitativi. Under a further aspect, the present invention relates to a pressurized spray device having a spray actuator and a container connected to said actuator, comprising the dry sprayable composition and at least one propellant agent. The features and advantages of the present invention will become apparent from the following detailed description and from the embodiments provided by way of illustrative and non-limiting examples.
DESCRIZIONE DETTAGLIATA DELL'INVENZIONE DETAILED DESCRIPTION OF THE INVENTION
L’invenzione riguarda pertanto una composizione spruzzabile secca 60-90% in peso di un agente cicatrizzante comprendente ossido di zinco, fino a 5% in peso di un agente antibatterico comprendente sale di argento, e fino a 5% in peso di olio essenziale antinfiammatorio, sul peso della composizione spruzzabile. The invention therefore relates to a dry sprayable composition 60-90% by weight of a healing agent comprising zinc oxide, up to 5% by weight of an antibacterial agent comprising silver salt, and up to 5% by weight of anti-inflammatory essential oil. , on the weight of the sprayable composition.
Si è infatti sorprendentemente trovato che la composizione dell’ invenzione consente sia la riepitelizzazione della cute lesa in tempi ridotti, sia una buona aderenza alla pelle che una ottimale tollerabilità, ed al tempo stesso una buona capacità emolliente e lenitiva. Inoltre, consente di ottenere un soddisfacente effetto antibatterico, vantaggiosamente senza dover ricorrere all’uso di antibiotici. It was in fact surprisingly found that the composition of the invention allows both the re-epithelialization of the injured skin in a short time, and a good adherence to the skin and an optimal tolerability, and at the same time a good emollient and soothing capacity. Furthermore, it allows to obtain a satisfactory antibacterial effect, advantageously without having to resort to the use of antibiotics.
Con il termine “sale di argento” si intende ossido di argento, argento cloruro, argento nitrato, argento nitrito, argento carbonato, argento acetato, argento solfato, argento solfuro, argento tiocianato, argento fosfato, argento per clorato, argento tetrafluoro borato, argento acetilacetonato, argento carbossilato, argento lattato, argento ossalato, e loro combinazioni. The term "silver salt" means silver oxide, silver chloride, silver nitrate, silver nitrite, silver carbonate, silver acetate, silver sulfate, silver sulfide, silver thiocyanate, silver phosphate, silver for chlorate, silver tetrafluoro borate, silver acetylacetonate, silver carboxylate, silver lactate, silver oxalate, and their combinations.
Preferibilmente, detto sale di argento è argento cloruro. Preferably, said silver salt is silver chloride.
Preferibilmente, la composizione dell’invenzione comprende 65-85% in peso di un agente cicatrizzante comprendente ossido di zinco. Preferably, the composition of the invention comprises 65-85% by weight of a healing agent comprising zinc oxide.
Preferibilmente, nella composizione spruzzabile secca dell’ invenzione, detto agente cicatrizzante comprende almeno 90% in peso di ossido di zinco, sul peso dell’agente cicatrizzante. Preferably, in the dry sprayable composition of the invention, said healing agent comprises at least 90% by weight of zinc oxide, based on the weight of the healing agent.
In forme di realizzazione preferite, detto agente cicatrizzante ulteriormente comprende un olio essenziale cicatrizzante scelto tra olio essenziale di Aglio, Arnica, Cajeput, Cipolla, Eucalipto, Fu genia, Geranio, Ginepro, Issopo, Lavanda, Niaouli, Rosmarino, Salvia, Santoreggia, Trementina, e loro miscele. In preferred embodiments, said healing agent further comprises an essential healing oil selected from essential oils of Garlic, Arnica, Cajeput, Onion, Eucalyptus, Fu genia, Geranium, Juniper, Hyssop, Lavender, Niaouli, Rosemary, Sage, Savory, Turpentine , and their mixtures.
Preferibilmente, detto olio essenziale cicatrizzante è Arnica, Lavanda, o loro miscela. Preferibilmente, la composizione dell’invenzione comprende fino a 4% in peso di un agente antibatterico comprendente sale di argento. Preferably, said healing essential oil is Arnica, Lavender, or their mixture. Preferably, the composition of the invention comprises up to 4% by weight of an antibacterial agent comprising silver salt.
Preferibilmente, nella composizione spruzzabile secca dell’ invenzione, detto agente antibatterico comprende fino a 1% in peso di sale di argento, sul peso dell’agente antibatterico. Preferably, in the dry sprayable composition of the invention, said antibacterial agent comprises up to 1% by weight of silver salt, based on the weight of the antibacterial agent.
In altre forme di realizzazione preferite, detto agente antibatterico ulteriormente comprende un olio essenziale antibatterico scelto tra olio essenziale di Melaleuca, Camomilla, Timo, Menta Piperita, Origano, Melissa, Lime, Limone, Elicriso, Chiodi di Garofano, Cannella, Cassia, Basilico, e loro miscele. In other preferred embodiments, said antibacterial agent further comprises an antibacterial essential oil selected from the essential oil of Melaleuca, Chamomile, Thyme, Peppermint, Oregano, Lemon balm, Lime, Lemon, Helichrysum, Cloves, Cinnamon, Cassia, Basil, and their mixtures.
Preferibilmente, detto olio essenziale antibatterico è olio essenziale di Melaleuca, Camomilla, o loro miscela. Preferably, said antibacterial essential oil is essential oil of Melaleuca, Chamomile, or their mixture.
Preferibilmente, la composizione dell’ invenzione comprende fino a 3% in peso di un olio essenziale antinfiammatorio. Preferably, the composition of the invention comprises up to 3% by weight of an anti-inflammatory essential oil.
In forme di realizzazione preferite, detto olio essenziale antinfiammatorio è scelto tra olio essenziale di Calendula, Artiglio del Diavolo, Ananas, Finocchio, Eucalipto, Timo, Chiodi di Garofano, Bergamotto, Lavanda, Malva, Spirea Ulmaria, Pino Pumilio, Verbena, Zenzero, e loro miscele. In preferred embodiments, said anti-inflammatory essential oil is selected from essential oil of Calendula, Devil's Claw, Pineapple, Fennel, Eucalyptus, Thyme, Cloves, Bergamot, Lavender, Mallow, Spirea Ulmaria, Pino Pumilio, Verbena, Ginger, and their mixtures.
Preferibilmente, detto olio essenziale antinfiammatorio è olio essenziale di Calendula, Artiglio del Diavolo, Ananas, Malva, Spirea Ulmaria, o loro miscela. Preferably, said anti-inflammatory essential oil is essential oil of Calendula, Devil's Claw, Pineapple, Mallow, Spirea Ulmaria, or their mixture.
Preferibilmente, la composizione spruzzabile secca dell’invenzione comprende 65-85% in peso di un agente cicatrizzante comprendente ossido di zinco, fino a 4% in peso di un agente antibatterico comprendente sale di argento, e fino a 3% in peso di olio essenziale antinfiammatorio, sul peso della composizione spruzzabile. Preferably, the dry sprayable composition of the invention comprises 65-85% by weight of a healing agent comprising zinc oxide, up to 4% by weight of an antibacterial agent comprising silver salt, and up to 3% by weight of essential oil anti-inflammatory, on the weight of the sprayable composition.
Più preferibilmente, la composizione spruzzabile secca dell’ invenzione comprende 65-80% in peso di un agente cicatrizzante comprendente ossido di zinco, fino a 3% in peso di un agente antibatterico comprendente sale di argento, e fino a 2% in peso di olio essenziale antinfiammatorio, sul peso della composizione spruzzabile. More preferably, the dry sprayable composition of the invention comprises 65-80% by weight of a healing agent comprising zinc oxide, up to 3% by weight of an antibacterial agent comprising silver salt, and up to 2% by weight of oil. essential anti-inflammatory, on the weight of the sprayable composition.
Vantaggiosamente, la composizione può ulteriormente comprendere olii emollienti ed agenti inerti. In particolare, adatti olii emollienti sono CI 2- 15 alchil benzoato, PEG-6 caprilic capric gliceridi, cetearil isononanoato, cetearil etilesanoato, cococaprilato, dibutiladipato, isodecil oleato, dietilesiladipato, dicaprilil etere, esildecanolo, esil decil laurato, ottil dodecanolo, glicereth-17 cocoato, triisostearina, PEG-7 glicerilcocoato, isostearil isostearato, isononil isononanoato, miristil lattato, miristil miristato, ottil dodecil miristato, etilesil palmitato, etilesil stearato, propilene glicol dicaprilato dicaprato, PEG-7 glicerilcocoato, PEG-200 idrogenato gliceril palmato, caprilic- capric trigliceride, o loro miscela. Advantageously, the composition can further comprise emollient oils and inert agents. In particular, suitable emollient oils are CI 2-15 alkyl benzoate, PEG-6 caprilic capric glycerides, cetearyl isononanoate, cetearyl ethylhexanoate, cococaprilat, dibutyladipate, isodecyl oleate, diethylhexyl adipate, dicapryl ether, hexyldecanol, hexyldecanol 17 cocoate, triisostearin, PEG-7 glyceryl cocoate, isostearyl isostearate, isononyl isononanoate, myristyl lactate, myristyl myristate, octyl dodecyl myristate, ethylhexyl palmitate, ethylhexyl stearate, propylene glycol dicaprilat dicaprate, PEG-7 glyceryl palmitate glyceryl dicaprate, PEG-7 glyceryl palmitate 200 - capric triglyceride, or their mixture.
Adatti agenti inerti sono biossido di titanio, talco, mica, caolino, sericite, ossido di alluminio, silice, fluorite, apatite, per lite, boro nitruro, o loro miscela. Suitable inert agents are titanium dioxide, talc, mica, kaolin, sericite, aluminum oxide, silica, fluorite, apatite, per lite, boron nitride, or a mixture thereof.
In forme di realizzazione preferite, nella composizione spruzzabile secca delPinvenzione, detto agente cicatrizzante consiste in ossido di zinco ed olio essenziale di Arnica, detto agente antibatterico consiste in sale di argento e olio essenziale di Melai euca, e detto olio essenziale antinfiammatorio consiste in olio essenziale di Calendula. In preferred embodiments, in the dry sprayable composition of the invention, said healing agent consists of zinc oxide and Arnica essential oil, said antibacterial agent consists of silver salt and essential oil of Melai euca, and said anti-inflammatory essential oil consists of essential oil. of Calendula.
In forme di realizzazione particolarmente preferite, la composizione dell’invenzione comprende ossido di zinco, titanio biossido, argento cloruro, olio essenziale di calendula, olio essenziale di arnica, olio essenziale di melaleuca, etilesil stearato ed un colorante alimentare. In particularly preferred embodiments, the composition of the invention comprises zinc oxide, titanium dioxide, silver chloride, calendula essential oil, arnica essential oil, tea tree essential oil, ethylhexyl stearate and a food coloring.
In altre forme di realizzazione, la composizione dell’invenzione comprende ossido di zinco, titanio biossido, argento cloruro, olio essenziale di artiglio del diavolo, olio essenziale di malva, olio essenziale di lavanda, etilesil stearato, ed un colorante alimentare. In other embodiments, the composition of the invention comprises zinc oxide, titanium dioxide, silver chloride, devil's claw essential oil, mallow essential oil, lavender essential oil, ethylhexyl stearate, and a food coloring.
In ulteriori forme di realizzazione, la composizione dell’invenzione comprende ossido di zinco, titanio biossido, argento cloruro, olio essenziale di ananas, olio essenziale di spirea ulmaria, olio essenziale di camomilla, etilesil stearato, ed un colorante alimentare. In further embodiments, the composition of the invention comprises zinc oxide, titanium dioxide, silver chloride, pineapple essential oil, spirea ulmaria essential oil, chamomile essential oil, ethylhexyl stearate, and a food coloring.
In altre forme di realizzazione preferite, la composizione spruzzabile secca dell’ invenzione consiste essenzialmente in agente cicatrizzante, agente antibatterico, ed olio essenziale antinfiammatorio. Con “consiste essenzialmente in” si intende che gli unici ingredienti attivi per gli scopi della presente invenzione sono detti agente cicatrizzante, agente antibatterico, ed olio essenziale antinfiammatorio. In other preferred embodiments, the dry sprayable composition of the invention essentially consists of a healing agent, antibacterial agent, and anti-inflammatory essential oil. By "essentially consists of" it is meant that the only active ingredients for the purposes of the present invention are said healing agent, antibacterial agent, and anti-inflammatory essential oil.
In ulteriori forme di realizzazione preferite, la composizione spruzzabile secca dell’ invenzione consiste in agente cicatrizzante, agente antibatterico, olio essenziale antinfiammatorio, olii emollienti, ed agenti inerti. In further preferred embodiments, the dry sprayable composition of the invention consists of a healing agent, antibacterial agent, anti-inflammatory essential oil, emollient oils, and inert agents.
La composizione dell’ invenzione può essere preparata secondo metodi noti di miscelazione intima dei componenti sopra descritti. The composition of the invention can be prepared according to known methods of intimate mixing of the components described above.
Sotto un altro aspetto, la presente invenzione concerne l’uso topico esterno della composizione spruzzabile secca nel trattamento di affezioni cutanee animali, in cui detta composizione è applicata per spruzzatura. From another aspect, the present invention concerns the external topical use of the dry sprayable composition in the treatment of animal skin diseases, in which said composition is applied by spraying.
Come detto, tali affezioni cutanee sono macchie, papule, vesciche, bolle, pustole, cisti, erosioni, abrasioni, arrossamenti, ulcere, screpolature, piaghe, telang ectasia, desquamazioni, eritemi, croste, lichenificazioni, escoriazioni, indurimenti, tagli, lacerazioni, o atrofie. Tali affezioni cutanee sono la manifestazione di malattie della cute scelte tra dermatiti, dermatiti digitali ed interdigitali, pododermatiti, piodermiti, dermatosi, foruncolosi, candidosi, eritrodermia, eritema, ustioni, follicolite, tricomicosi, cheratite, eczema, psoriasi, porocheratosi, orticaria, rogna demodettica, malasseziasi, parassitosi, ascessi, flemmoni, zoppina. As mentioned, these skin diseases are spots, papules, blisters, bubbles, pustules, cysts, erosions, abrasions, redness, ulcers, cracks, sores, telang ectasia, desquamations, erythema, crusts, lichenifications, excoriations, hardening, cuts, lacerations, or atrophies. These skin diseases are the manifestation of skin diseases chosen from dermatitis, digital and interdigital dermatitis, pododermatitis, pyoderma, dermatosis, furunculosis, candidiasis, erythroderma, erythema, burns, folliculitis, trichomycosis, keratitis, eczema, psoriasis, porokeratosis, urticaria, rash demodectics, malasseziasis, parasites, abscesses, phlegmons, limp.
La composizione dell’invenzione agisce in modo rapido ed efficace sulla cute animale disinfettando e riepitelizzando velocemente, al tempo stesso mantenendo la cute adeguatamente idratata e morbida. The composition of the invention acts quickly and effectively on animal skin by disinfecting and re-epithelializing quickly, at the same time keeping the skin adequately hydrated and soft.
Preferibilmente, la composizione dell’invenzione è applicata per spruzzatura, offrendo una buona aderenza alla cute, sia danneggiata che sana, la formazione di una pellicola protettiva, una drastica riduzione del prurito, ed un tempo di permanenza sulla stessa adeguato alle tempistiche di guarigione desiderate. Preferably, the composition of the invention is applied by spraying, offering a good adherence to the skin, both damaged and healthy, the formation of a protective film, a drastic reduction of itching, and a residence time on it suitable for the desired healing times. .
La composizione dell’invenzione è a rapida essiccazione e non occlusiva, cosicché offre un notevole miglioramento della cute per permeazione dell’agente antibatterico, una maggiore facilità di utilizzo, ed una elevata flessibilità di dosaggio. The composition of the invention is fast drying and non-occlusive, so that it offers a significant improvement of the skin by permeation of the antibacterial agent, greater ease of use, and high dosage flexibility.
L’applicazione per spruzzatura offre inoltre l’evidente vantaggio di evitare il contatto fisico con la cute danneggiata, rendendo quindi l’applicazione stessa molto più igienica e pratica. The application by spraying also offers the obvious advantage of avoiding physical contact with damaged skin, thus making the application itself much more hygienic and practical.
La composizione dell’ invenzione, una volta spruzzata, mostra eccellente stabilità nel tempo ed eccellente adesione alla cute, sia sana che lesionata, cosicché risulta vantaggiosamente elevato il tempo di contatto tra la composizione stessa e la cute da trattare. Tale eccellente adesione si manifesta nella formazione di uno strato compatto e stabile, che non gocciola né si altera una volta applicato. Qualora fosse poi necessario rimuovere la composizione, è sufficiente lavare con acqua la cute trattata. The composition of the invention, once sprayed, shows excellent stability over time and excellent adhesion to the skin, both healthy and damaged, so that the contact time between the composition itself and the skin to be treated is advantageously high. This excellent adhesion manifests itself in the formation of a compact and stable layer, which does not drip or deteriorate once applied. If it is then necessary to remove the composition, it is sufficient to wash the treated skin with water.
Sotto un altro aspetto, la presente invenzione concerne anche un dispositivo spruzzatore a pompa manuale avente un attuatore spray ed un contenitore, connesso a detto attuatore, comprendente la composizione dell’ invenzione. In genere, in tali dispositivi non è necessario Γ impiego di un agente propellente, tuttavia facoltativamente esso può essere presente. Under another aspect, the present invention also relates to a manual pump spray device having a spray actuator and a container, connected to said actuator, comprising the composition of the invention. Generally, in such devices it is not necessary to use a propellant, however it may optionally be present.
Alternativamente e preferibilmente, la presente invenzione concerne un dispositivo spruzzatore pressurizzato avente un attuatore spray ed un contenitore connesso a detto attuatore, comprendente la composizione dell’ invenzione ed almeno un agente propellente. Alternatively and preferably, the present invention relates to a pressurized spray device having a spray actuator and a container connected to said actuator, comprising the composition of the invention and at least one propellant agent.
Adatti agenti propellenti sono liquidi a temperatura ambiente e possono essere idrocarburi, quali propano, butano, isobutano, dimetiletere; idrofluorocarburi ed idrocloro fluorocarburi, quali diclorodifluorometano (PI 2), tricloromonofluorometano (PI I), diclorofluoroetano, monoclorodifluoro metano (P22), diclorotetrafluoroetano (PI 14), difluoroetano (PI52a), tetrafluoroetano (I34a), eptafluoropropano (P227b); e gas compressi, quali azoto e anidride carbonica. Suitable propellants are liquid at room temperature and can be hydrocarbons, such as propane, butane, isobutane, dimethyl ether; hydrofluorocarbons and hydrochlorofluorocarbons, such as dichlorodifluoromethane (PI 2), trichloromonofluoromethane (PI I), dichlorofluoroethane, monochlorodifluoro methane (P22), dichlorotetrafluoroethane (PI 14), difluoroethane (PI52a), tetrafluoroethane (Ip22a), hepfluoroethane (I22a); and compressed gases, such as nitrogen and carbon dioxide.
Preferibilmente, detto agente propellente è propano, butano, isobutano o loro miscela. In forme di realizzazione preferite, detto dispositivo spruzzatore pressurizzato comprende 5-20% di composizione dell’invenzione e 95-80% di almeno un agente propellente. Più preferibilmente, esso comprende 10-16% di composizione dell’invenzione e 90-84% di almeno un agente propellente. Preferably, said propellant agent is propane, butane, isobutane or their mixture. In preferred embodiments, said pressurized spray device comprises 5-20% of the composition of the invention and 95-80% of at least one propellant agent. More preferably, it comprises 10-16% of the composition of the invention and 90-84% of at least one propellant.
Preferibilmente, il dispositivo spruzzatore è sottoposto a sterilizzazione, più preferibilmente a sterilizzazione con raggi gamma dopo il suo riempimento con il prodotto. Preferably, the spraying device is subjected to sterilization, more preferably to gamma-ray sterilization after its filling with the product.
È da intendersi che tutti gli aspetti identificati come preferiti e vantaggiosi per la composizione sono da ritenersi analogamente preferiti e vantaggiosi anche per il dispositivo spruzzatore, ed loro usi. It is to be understood that all the aspects identified as preferred and advantageous for the composition are to be considered similarly preferred and advantageous also for the spraying device, and their uses.
Sono inoltre da ritenersi descritte anche tutte le combinazioni di aspetti preferiti e forme Furthermore, all combinations of preferred aspects and forms are also to be considered described
di realizzazione della composizione, del dispositivo spruzzatore, e loro usi, sopra of realization of the composition, of the spraying device, and their uses, above
riportati. reported.
Di seguito sono fomiti esempi di realizzazione della presente invenzione a titolo non Examples of embodiments of the present invention are given below by way of non-title
limitativo. limiting.
ESEMPI EXAMPLES
Esempio I. Example I.
È stata preparata una composizione miscelando i seguenti componenti nelle quantità A composition was prepared by mixing the following components in quantities
indicate in tabella: indicated in the table:
Componente % in peso Component% by weight
Ossido di Zinco 71,230% Zinc Oxide 71,230%
Titanio biossido 0,196% Titanium dioxide 0.196%
Argento cloruro 0,004% Silver chloride 0.004%
Olio essenziale di Calendula 0,25% Marigold essential oil 0.25%
Olio essenziale di Amica 0,25% Amica essential oil 0.25%
Olio essenziale di Melaleuca 2,50% Melaleuca essential oil 2.50%
Etilesil stearato 22,00% Ethylhexyl stearate 22.00%
Colorante alimentare 3,57% Food coloring 3.57%
TOTALE 100% TOTAL 100%
Esempio 2. Example 2.
È stato preparato un dispositivo spruzzatore pressurizzato comprendente 14% in peso A pressurized spray device comprising 14% by weight was prepared
della composizione delPEsempio 1 e 86% in peso di propano. of the composition of Example 1 is 86% by weight of propane.
Esempio 3. Example 3.
È stata preparata una composizione miscelando i seguenti componenti nelle quantità A composition was prepared by mixing the following components in quantities
indicate in tabella: indicated in the table:
Componente % in peso Component% by weight
Ossido di Zinco 71,230% Zinc Oxide 71,230%
Titanio biossido 0,196% Titanium dioxide 0.196%
Argento cloruro 0,004% Silver chloride 0.004%
Olio essenziale di artiglio del diavolo 0,25% Devil's claw essential oil 0.25%
Olio essenziale di Malva 0,25% Mallow essential oil 0.25%
Olio essenziale di Lavanda 2,50% Lavender essential oil 2.50%
Etilesil stearato 22,00% Ethylhexyl stearate 22.00%
Colorante alimentare 3,57% Food coloring 3.57%
TOTALE 100% TOTAL 100%
Esempio 4. Example 4.
È stato preparato un dispositivo spruzzatore pressurizzato comprendente 12% in peso della composizione delTEsempio 2 e 88% in peso di butano. A pressurized spray device was prepared comprising 12% by weight of the composition of Example 2 and 88% by weight of butane.
Esempio 5. Example 5.
È stata preparata una composizione miscelando i seguenti componenti nelle quantità indicate in tabella; A composition was prepared by mixing the following components in the quantities indicated in the table;
Componente % in peso Component% by weight
Ossido di Zinco 71,230% Titanio biossido 0,196% Argento cloruro 0,004% Olio essenziale di Ananas 0,25% Olio essenziale di Spirea Ulmaria 0,25% Olio essenziale di Camomilla 2,50% Etilesil stearato 22,00% Colorante alimentare 3,57% Zinc oxide 71.230% Titanium dioxide 0.196% Silver chloride 0.004% Pineapple essential oil 0.25% Spirea Ulmaria essential oil 0.25% Chamomile essential oil 2.50% Ethylhexyl stearate 22.00% Food coloring 3.57%
TOTALE 100% TOTAL 100%
Esempio 6. Example 6.
È stato preparato un dispositivo spruzzatore pressurizzato comprendente 15% in peso della composizione delTEsempio 3 e 85% in peso di azoto compresso. A pressurized spray device was prepared comprising 15% by weight of the composition of Example 3 and 85% by weight of compressed nitrogen.
Esempio 7. Example 7.
Sono state effettuate delle prove di efficacia della composizione delTEsempio 1 (brevemente “Es.l”) nei confronti dei seguenti ceppi batterici: Dichelobacter nodosus CCUG 27824 T e Fusobacterium necrophorum ATCC 25286. Tests of efficacy of the composition of Example 1 (briefly “Es.l”) were carried out against the following bacterial strains: Dichelobacter nodosus CCUG 27824 T and Fusobacterium necrophorum ATCC 25286.
Fusobacterium necrophorum e Dichelobacter nodosus (anche denominato Bacteroides nodosus) sono batteri anaerobi gram-negativi che possono causare la zoppina in animali quali pecore, capre, bovini, cervi e cavalli. In generale, le pecore sono colpite più gravemente delle capre. Fusobacterium necrophorum and Dichelobacter nodosus (also called Bacteroides nodosus) are gram-negative anaerobic bacteria that can cause limp in animals such as sheep, goats, cattle, deer and horses. In general, sheep are more severely affected than goats.
I batteri del ceppo Fusobacterium necrophorum causano anche una comune malattia nota come “foot scald” o dermatite interdigitale. Bacteria from the Fusobacterium necrophorum strain also cause a common disease known as foot scald or interdigital dermatitis.
I batteri del ceppo Dichelobacter nodosus sono in grado di vivere nel terreno solo per 10 a 14 giorni, ma possono sopravvivere nel zoccolo per periodi prolungati dato l’adatto ambiente anaerobico presente. Bacteria of the Dichelobacter nodosus strain are able to live in the soil for only 10 to 14 days, but can survive in the hoof for prolonged periods given the suitable anaerobic environment present.
Dichelobacter nodosus CCUG 27824 T Dichelobacter nodosus CCUG 27824 T
(tempo di contatto 10 minuti) (contact time 10 minutes)
Campione Risultato U.d.M. Metodo Soluzione madre (confronto) 680.000 UFC/ml conteggio Soluzione madre;Es.l = 1:1 100 UFC/ml conteggio Soluzione madre:Es.l = 1:2 <10 UFC/ml conteggio UdM Result Sample Method Stock solution (comparison) 680,000 CFU / ml count Stock solution; e.g. l = 1: 1 100 CFU / ml count Stock solution: e.g. l = 1: 2 <10 CFU / ml count
Fusobacterium necrophorum ATCC 25286 Fusobacterium necrophorum ATCC 25286
(tempo di contatto 10 minuti) (contact time 10 minutes)
Campione Risultato U.d.M. Metodo Soluzione madre (confronto) 850.000 UFC/ml conteggio Soluzione madre:Es.l = 1:1 200 UFC/ml conteggio Soluzione madre:Es.l = 1:2 <10 UFC/ml conteggio UdM Result Sample Method Stock solution (comparison) 850,000 CFU / ml count Stock solution: e.g. l = 1: 1 200 CFU / ml count Stock solution: e.g. l = 1: 2 <10 CFU / ml count
Si osservava quindi la notevole attività antibatterica della composizione dell’invenzione, a fronte di un tempo di contatto di soli 10 minuti. In particolare, per il rapporto 1:2, si osservava una riduzione quantitativa della carica batterica nei confronti di entrambi i ceppi batterici esaminati. The remarkable antibacterial activity of the composition of the invention was therefore observed, with a contact time of only 10 minutes. In particular, for the 1: 2 ratio, a quantitative reduction of the bacterial load was observed against both bacterial strains examined.
Poiché questi ultimi, come detto, sono responsabili di affezioni piuttosto comuni negli animali da allevamento, la composizione dell’invenzione risulta essere particolarmente indicata ed efficace. Since the latter, as mentioned, are responsible for rather common diseases in farm animals, the composition of the invention is particularly suitable and effective.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A005223A ITUB20155223A1 (en) | 2015-10-22 | 2015-10-22 | DRY SPRAYING COMPOSITION AND ITS EXTERNAL TOPIC USE IN VETERINARY APPLICATIONS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A005223A ITUB20155223A1 (en) | 2015-10-22 | 2015-10-22 | DRY SPRAYING COMPOSITION AND ITS EXTERNAL TOPIC USE IN VETERINARY APPLICATIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
ITUB20155223A1 true ITUB20155223A1 (en) | 2017-04-22 |
Family
ID=55315637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITUB2015A005223A ITUB20155223A1 (en) | 2015-10-22 | 2015-10-22 | DRY SPRAYING COMPOSITION AND ITS EXTERNAL TOPIC USE IN VETERINARY APPLICATIONS |
Country Status (1)
Country | Link |
---|---|
IT (1) | ITUB20155223A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002021926A2 (en) * | 2000-09-12 | 2002-03-21 | Barrier Biotech Limited | An antimicrobial composition |
CN101912517B (en) * | 2009-08-17 | 2013-01-30 | 黄汉贤 | Spray and gauze & ointment for preventing and curing bedsore and eczema |
WO2014191955A1 (en) * | 2013-05-30 | 2014-12-04 | Fidia Farmaceutici S.P.A. | Pharmaceutical compositions comprising collagen and sodium hyaluronate |
US20150231071A1 (en) * | 2014-02-14 | 2015-08-20 | Mission Pharmacal Company | Sprayable Composition Containing Zinc Oxide and a Fluoro-Olefin Propellant |
-
2015
- 2015-10-22 IT ITUB2015A005223A patent/ITUB20155223A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002021926A2 (en) * | 2000-09-12 | 2002-03-21 | Barrier Biotech Limited | An antimicrobial composition |
CN101912517B (en) * | 2009-08-17 | 2013-01-30 | 黄汉贤 | Spray and gauze & ointment for preventing and curing bedsore and eczema |
WO2014191955A1 (en) * | 2013-05-30 | 2014-12-04 | Fidia Farmaceutici S.P.A. | Pharmaceutical compositions comprising collagen and sodium hyaluronate |
US20150231071A1 (en) * | 2014-02-14 | 2015-08-20 | Mission Pharmacal Company | Sprayable Composition Containing Zinc Oxide and a Fluoro-Olefin Propellant |
Non-Patent Citations (1)
Title |
---|
ANONYMOUS: "RESOLVET LP", 20 April 2015 (2015-04-20), XP055278754, Retrieved from the Internet <URL:http://reprogenesis.pt/en/portfolio-view/resolvet/> [retrieved on 20160608] * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mueller et al. | A review of topical therapy for skin infections with bacteria and yeast | |
DE60129823T2 (en) | NITROGEN OXIDE FOR THE TREATMENT OF THERAPY-LIKE ORGANISMS | |
US8536228B2 (en) | Transdermal compositions | |
US4557935A (en) | Germicidal composition | |
EP2496215B1 (en) | Antimicrobial and anti-acne formulations | |
US20200179300A1 (en) | Topical Formulation Cures and Heals a Variety of Skin Conditions Including Ulcers, Decubitus Ulcers, Cancer, Abrasions and other Conditions and also accelerates the curing and healing of those Conditions | |
EP3156065A1 (en) | Hydrolyzed fibroin-containing ointment and production method therefor | |
WO2013103944A1 (en) | Compositions and methods for treating skin conditions | |
US20130209386A1 (en) | New uses | |
US20110189160A1 (en) | Veterinary Topical Agent | |
IL215641A (en) | Medicinal acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it | |
US20170333513A1 (en) | Decubitus Treatment System | |
ITUB20155223A1 (en) | DRY SPRAYING COMPOSITION AND ITS EXTERNAL TOPIC USE IN VETERINARY APPLICATIONS | |
EP2654746B1 (en) | Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt | |
Silapunt | The use of sodium sulfacetamide in dermatology | |
US9155709B1 (en) | Buffered hydroalcoholic povidone iodine composition and method | |
EP2403480A1 (en) | A process to make fusidic acid cream | |
Sakthibalan et al. | Evaluation of wound healing effect of colostrum and curcumin cream in rat excision wound model | |
JP2006232716A (en) | Externally applied agent | |
GR1009906B (en) | Paste for the prevention and therapy of bedsores and decubitus ulcers - production method thereof | |
IT201900006493A1 (en) | DERMATOLOGICAL CREAM FOR THE TREATMENT AND PREVENTION OF SKIN DISEASES IN ONCOLOGICAL FIELD | |
JPS63208530A (en) | Liquid drug for athlete's foot | |
CS276813B6 (en) | Preparation for hemorrhoids treatment | |
ITMI992566A1 (en) | DERMATOLOGICAL COMPOSITION FOR THE TOPICAL TREATMENT OF SKIN DISEASES |